DNAnexus
a 17-year multiomics pioneer positioning its managed-data cloud as "AI fuel" for precision health; under CEO Thomas Laur it pushes a federated "move algorithms to data" model and reported 90% customer satisfaction in July 2026 amid global expansion.
- Country
- United States
Commercial
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| bioinformatics-omics | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biological AI & bioinformation services | bioinformatics-omics | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.